Author:
Ren Rutong,Shi Chunyan,Cao Jing,Sun Yi,Zhao Xin,Guo Yongfei,Wang Chen,Lei Hui,Jiang Hanjie,Ablat Nuramatjan,Xu Jiamin,Li Wan,Ma Yingcong,Qi Xianrong,Ye Min,Pu Xiaoping,Han Hongbin
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Reeve, A., Simcox, E. & Turnbull, D. Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Res. Rev. 14, 19–30 (2014).
2. Dauer, W. & Przedborski, S. Parkinson’s disease: mechanisms and models. Neuron 39, 889–909 (2003).
3. Tian, L. et al. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. PLoS One 7, e31439 (2012).
4. Klusa, V. Z. et al. Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson’s disease. Int. J. Mol. Sci. 11, 4465–4487 (2010).
5. Calou, I. et al. Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertao), as Evaluated by a Parkinson’s Disease Model in Rats. Parkinsons Dis. 2014, 519615 (2014).
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献